Beta Trial Clause Samples

Beta Trial. Subscriber may choose to participate in testing of the Beta Features in their live environment and under normal operating conditions as further set forth herein (the “Beta Trial”). Subscriber will subject the Beta feature to normal workload and cooperate in the identification, isolation, documentation and reporting of any and all problems encountered. If Subscriber encounters a significant problem with or deficiency with a Beta Feature, it shall report the same to Magentrix personnel as soon as practicable. Magentrix may contact Subscriber during normal business hours by telephone or e-mail and Subscriber agrees to completely and accurately respond to questions and surveys regarding the performance of the Beta Features. Subscriber acknowledges and agrees that Magentrix is under no obligation to incorporate into the Beta Features or the Software, any changes, suggestions, or comments made by Subscriber; Subscriber further waives any and all proprietary right or interest in any such changes, suggestions, or comments communicated by Subscriber to Magentrix and assigns to Magentrix any and all rights therein.
View SourceView Similar (4)
Beta Trial. To the extent you participate in a beta trial of the Plugin, the terms of this subsection apply to the beta trial notwithstanding any other provision in any other agreement between the parties. If you are not participating in a beta trial of the Plugin, the language in Section 7.4 a., b., c., d., and e. below is void and without effect. a. Beta Features are in development. You may accept or decline Beta Features in your sole discretion. You acknowledge that your use of Beta Features is at your sole risk. b. Beta Features may receive specialized support and/or may not receive full support and are excluded from the Agreement’s SLA obligations attributable to dbt Labs. c. dbt Labs may modify or discontinue Beta Features or end your access to the Beta Features, in whole or in part, at any time, in its sole discretion, with or without notice, and may never generally release the Beta Features. Elements of the Beta Features, Privacy Policy, or Documentation may be under development and released, modified, or updated prior to general release. d. In the event Beta Features become available for purchase, you agree to either cease using the Beta Features or purchase by entering into an ordering document agreed to between the parties. dbt Labs reserves the right to suspend or terminate access to the Beta Features in the event Client does not comply with this subsection. e. BETA FEATURES ARE PROVIDED WITH NO WARRANTIES OF ANY KIND WHATSOEVER WHETHER EXPRESS OR IMPLIED, INCLUDING, BUT NOT LIMITED TO, THOSE OF MERCHANTABILITY, QUALITY, TITLE, FITNESS FOR A PARTICULAR PURPOSE AND NON-INFRINGEMENT. CLIENT ACKNOWLEDGES AND AGREES THAT BETA FEATURES ARE NOT IN SCOPE FOR DBT LABS’S SOC 2 TYPE II AND OTHER INDEPENDENT SECURITY AUDITS AND SECURITY CERTIFICATIONS. TO THE MAXIMUM EXTENT PERMITTED BY APPLICABLE LAW AND NOTWITHSTANDING ANY OTHER PROVISION HEREIN, DBT LABS WILL HAVE NO LIABILITY OR ANY INDEMNITY OBLIGATIONS FOR ANY HARM OR DAMAGE ARISING OUT OF OR IN CONNECTION WITH ANY BETA FEATURES, INCLUDING, WITHOUT LIMITATION, ANY DIRECT OR INDIRECT, CONSEQUENTIAL OR INCIDENTAL DAMAGES AND DBT LABS’S AGGREGATE LIABILITY TO CLIENT IN CONNECTION WITH BETA FEATURES, WHETHER SUCH DAMAGES ARE BASED IN CONTRACT, TORT OR OTHER LEGAL THEORY, WILL NOT EXCEED ONE HUNDRED U.S. DOLLARS ($100).
View Source

Related to Beta Trial

  • Study An application for leave of absence for professional study must be supported by a written statement indicating what study or research is to be undertaken, or, if applicable, what subjects are to be studied and at what institutions.

  • Clinical Studies The animal and other preclinical studies and clinical trials conducted by the Company or on behalf of the Company were, and, if still pending are, to the Company’s knowledge, being conducted in all material respects in compliance with all Applicable Laws and in accordance with experimental protocols, procedures and controls generally used by qualified experts in the preclinical study and clinical trials of new drugs and biologics as applied to comparable products to those being developed by the Company; the descriptions of the results of such preclinical studies and clinical trials contained in the Registration Statement and the Prospectus are accurate and complete in all material respects, and, except as set forth in the Registration Statement and the Prospectus, the Company has no knowledge of any other clinical trials or preclinical studies, the results of which reasonably call into question the clinical trial or preclinical study results described or referred to in the Registration Statement and the Prospectus when viewed in the context in which such results are described; and the Company has not received any written notices or correspondence from the FDA, the EMA, or any other domestic or foreign governmental agency requiring the termination, suspension or modification of any preclinical studies or clinical trials conducted by or on behalf of the Company that are described in the Registration Statement and the Prospectus or the results of which are referred to in the Registration Statement and the Prospectus.

  • Clinical 1.1 Provides comprehensive evidence based nursing care to patients including assessment, intervention and evaluation. 1.2 Undertakes clinical shifts at the direction of senior staff and the Nursing Director including participation on the on-call/after hours/weekend roster if required. 1.3 Participates in ▇▇▇▇ rounds/case conferences as appropriate. 1.4 Educates patients/carers in post discharge management and organises discharge summaries/referrals to other services, as appropriate. 1.5 Supports and liaises with patients, carers, colleagues, medical, nursing, allied health, support staff, external agencies and the private sector to provide coordinated multidisciplinary care. 1.6 Completes clinical documentation and undertakes other administrative tasks as required. 1.7 Participates in departmental and other meetings as required to meet organisational and service objectives. 1.8 Participates in quality improvement and policy review/development within the practice setting. 1.9 Complies with and demonstrates a positive commitment to Regulations, Acts and Policies relevant to nursing including the Code of Ethics for Nurses in Australia, the Code of Conduct for Nurses in Australia, the National Competency Standards for the Registered Nurse and the Poisons Act 1964. 1.10 Promotes and participates in team building and decision making. 1.11 Responsible where applicable for the clinical supervision of Enrolled Nurses/Assistants in Nursing under their supervision.

  • The Study 1The parties must comply with, and conduct the Study in accordance with, the Protocol and any conditions of the Reviewing HREC. In addition the parties must comply with the following, as applicable: